Oncurie focuses on creating the technology to deliver radionuclides selectively to metastatic tissue to treat metastatic cancer.
Oncurie has raised $75K in total funding. The most recent round was Grant. The last funding was announced in September 2022.
Oncurie's investors include National Science Foundation, One North Carolina Small Business Program.
Oncurie is headquartered in Raleigh, United States.
Oncurie focuses on creating the technology to deliver radionuclides selectively to metastatic tissue to treat metastatic cancer.
Oncurie is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncurie — Funding & Investors." VCBacked, September 22, 2022, https://www.vcbacked.co/company/oncurie. Accessed November 13, 2026.
VCBacked. (2022). Oncurie — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/oncurie
{{cite web |title=Oncurie — Funding & Investors |url=https://www.vcbacked.co/company/oncurie |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Oncurie? Request a listing update